Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
22%
Ph phase_1
3
33%
Ph phase_3
4
44%

Phase Distribution

3

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
4(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(9)

Detailed Status

Completed9

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (33.3%)
Phase 22 (22.2%)
Phase 34 (44.4%)

Trials by Status

completed9100%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients

NCT01989429
completedphase_2

Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients

NCT01301157
completedphase_3

Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

NCT01873677
completedphase_3

Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

NCT01878461
completedphase_3

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

NCT01908595
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT01989429Phase 3

Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients

Completed
NCT01301157Phase 2

Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients

Completed
NCT01873677Phase 3

Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Completed
NCT01878461Phase 3

Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Completed
NCT01908595Phase 3

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Completed
NCT02256930Phase 1

Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers

Completed
NCT02227069Phase 1

Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers

Completed
NCT01844973Phase 1

Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

Completed
NCT00884169Phase 2

Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9